GENB
Generate Biomedicines, Inc.
NASDAQ · Financial Services · Asset Management · US
$17.14
+0.12%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 109.18x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.82x
- Price / sales
- 68.98x
- Price / cash flow
- -10.97x
Enterprise value
- Enterprise value
- $1.8B
- EV / sales
- 56.60x
- EV / EBITDA
- -8.66x
- EV / EBIT
- -7.68x
- Market cap
- $2.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026